Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CANNABIS SCIENCE, INC.

SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cannabis Science Partners With NHS Industries to Launch the CBIS CDN Economic Development Plan

08/28/2019 | 12:30am EST

Cannabis Science, Inc. announced that Company has signed a joint venture agreement with NHS Industries Ltd. The group will focus on job creation, deliver and develop public and private access educational content, and research various delivery platforms for medical cannabinoid-related products and services, all based on the CBIS Economic Development Plan for Canada. The new Canadian-based partnership will expand Cannabis Science's existing operations into Canada through its CDN EDP. CBIS will utilize its relationships with the Harvard International Phytomedicines and Medical Cannabis Institute as well as the company's collaborations with other leading institutions, to build and deliver educational content for the CDN EDP for the Canadian public. The focus of the CDN EDP is to create jobs, research and educate the Canadian general public on the potential uses of medical cannabis to treat a variety of critical ailments and industrial uses.


ę S&P Capital IQ 2019
All news about CANNABIS SCIENCE, INC.
08/10Cannabis Science Inc. Successfully Launches its $CSI Cannabis Science Coin for its CSi-..
CI
03/31Thermic Sciences International signed a share exchange agreement to acquire Cannabis Sc..
CI
2019CANOPY GROWTH : BC Centre on Substance Use hosts inaugural Cannabis Science Symposium
AQ
2019NHS Industries, Ltd. and Cannabis Science, Inc. Agree to Terminate the Previously Annou..
CI
2019Cannabis Science Enters Transition Stage as Trading of the Company's Shares is Halted; ..
GL
2019Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic ..
GL
2019Cannabis Science Partners With NHS Industries to Launch the CBIS CDN Economic Developme..
CI
2019Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing N..
GL
2019Cannabis Science Successfully Completes European Headquarters and Operations Move to Th..
GL
2019Cannabis Science Successfully Moves Operations to The Netherlands and Completes Shut Do..
CI
More news
Managers and Directors
Raymond C. Dabney President, Chief Executive Officer & Director
Richard Ogden Chief Scientific Officer
Julius Garvey Chief Medical Officer
Robert Kane Chief Operating Officer & Director
Ronald V. Dellums President-Government Affairs
Sector and Competitors
1st jan.Capi. (M$)
CANNABIS SCIENCE, INC.-86.00%13
GILEAD SCIENCES, INC.19.40%87 255
BIONTECH SE310.30%83 098
REGENERON PHARMACEUTICALS31.23%66 409
WUXI APPTEC CO., LTD.26.31%65 758
VERTEX PHARMACEUTICALS-13.76%51 819